UnknownNot Applicable

Efficacy of Adjunctive Low-Level Light Therapy to Intense Pulsed Light for Meibomian Gland Dysfunction

Thailand58 participantsStarted 2024-10-02

Plain-language summary

The goal of this clinical trial is to compare the effectiveness of adjunctive low-level light therapy (LLLT) to intense pulsed light (IPL) versus intense pulsed light (IPL) alone for the treatment of meibomian gland dysfunction (MGD). The main question it aims to answer is does the adjunctive of low-level light therapy (LLLT) to intense pulsed light (IPL) provide more beneficial treatment effects than intense pulsed light (IPL) alone in treating meibomian gland dysfunction (MGD) patients? Participants will be randomized into 2 groups: adjunctive low-level light therapy (LLLT) to intense pulsed light (IPL) group (ALLLT +IPL) and IPL alone group.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * MGD severity level 2 and above according to the international workshop on MGD * Fitzpatrick skin type of 1-4 according to sun sensitivity characteristics and appearance of the skin color Exclusion Criteria: * History of previous ocular trauma or surgery within the past six months * Contact lens-wearing patients * Patients with skin-pigmented lesions in the treatment area * Pregnancy or breastfeeding patients * Patients with any uncontrolled ocular or systemic diseases

What they're measuring

Lipid layer thickness (LLT)

Timeframe: baseline, 2 weeks, 4 weeks, 12 weeks, and 24 weeks post treatment

Trial details

NCT IDNCT06468930

SponsorChulalongkorn University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05

Contact for this trial

Chatchada Kharuhayothin

+66922496151 chatchada.kharuhayothin@gmail.com

View on ClinicalTrials.gov More MGD-Meibomian Gland Dysfunction trials